University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor
Print this page
FONT SIZE
Home > Doctors > George F. Sawaya

George F. Sawaya, M.D.

Obstetrician and gynecologist

Dr. George Sawaya is an obstetrician-gynecologist and an associate professor in Obstetrics, Gynecology and Reproductive Sciences. His main research interest is in cervical cancer screening with particular interest in screening older women, cost-effectiveness and cost-utility as well as new approaches to population-based screening. He is the director San Francisco General Hospital's Colposcopy and Cervical Dysplasia Clinic.

Sawaya earned a medical degree at the Vanderbilt University School of Medicine, his internship and residency at UCSF and a fellowship in UCSF's Department of Epidemiology and Biostatistics. He is a lecturer and author or coauthor of articles in peer-reviewed journals and book chapters.

Conditions & Treatments

Clinics

Dysplasia Clinic
1600 Divisadero St., Fourth Floor
San Francisco, CA 94143
Phone: (415) 353- 7100
Fax: (415) 353- 4298

Hours: Monday to Friday
8 a.m. – 5 p.m.

More about George F. Sawaya

Additional Languages

French

Education

Vanderbilt 1990

Selected Research and Publications

  1. Sawaya GF. Pelvic examinations in asymptomatic women: tipping a sacred cow: comment on "the pelvic examination as a screening tool". Arch Intern Med. 2011 Dec 12; 171(22):2054-5.
  2. Diouf K, Sawaya GF, Shiboski S, Magure T, Makunike-Mutasa R, Darragh TM, Tuveson J, Chipato T, Palefsky JM, Moscicki AB, Chirenje M, Smith-McCune K. Investigating Potential Associations between Cervical Procedures and HIV Acquisition. ISRN Obstet Gynecol. 2011; 2011:789106.
  3. Sawaya GF, Jacoby V. Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay. Obstet Gynecol. 2011 Nov; 118(5):1178; author reply 1178-9.
  4. Harris R, Sawaya GF, Moyer VA, Calonge N. Reconsidering the criteria for evaluating proposed screening programs: reflections from 4 current and former members of the U.S. Preventive services task force. Epidemiol Rev. 2011; 33(1):20-35.
  5. Gregory KD, Sawaya GF. Updated recommendations for breast cancer screening. Curr Opin Obstet Gynecol. 2010 Dec; 22(6):498-505.
  6. Henderson JT, Sawaya GF, Blum M, Stratton L, Harper CC. Pelvic examinations and access to oral hormonal contraception. Obstet Gynecol. 2010 Dec; 116(6):1257-64.
  7. Melnikow J, Kulasingam S, Slee C, Helms LJ, Kuppermann M, Birch S, McGahan CE, Coldman A, Chan BK, Sawaya GF. Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness. Obstet Gynecol. 2010 Nov; 116(5):1158-70.
  8. Sawaya GF, Gregory KD. The new mammographic screening guidelines: what were they thinking? Obstet Gynecol. 2010 Nov; 116(5):1216; author reply 1216-7.
  9. Kuppermann M, Melnikow J, Slee C, Tancredi DJ, Kulasingam S, Birch S, Helms LJ, Bayoumi AM, Sawaya GF. Preferences for surveillance strategies for women treated for high-grade precancerous cervical lesions. Gynecol Oncol. 2010 Aug 1; 118(2):108-15.
  10. Sawaya GF. Rightsizing cervical cancer screening: comment on "Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone". Arch Intern Med. 2010 Jun 14; 170(11):985-6.
  11. Smith-McCune KK, Shiboski S, Chirenje MZ, Magure T, Tuveson J, Ma Y, Da Costa M, Moscicki AB, Palefsky JM, Makunike-Mutasa R, Chipato T, van der Straten A, Sawaya GF. Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PLoS One. 2010; 5(4):e10094.
  12. Smith-McCune K, Sawaya GF. Update on quadrivalent human papillomavirus vaccination and pregnancy outcomes: is contraception advisable? Obstet Gynecol. 2009 Dec; 114(6):1168-9.
  13. Sawaya GF. Cervical-cancer screening--new guidelines and the balance between benefits and harms. N Engl J Med. 2009 Dec 24; 361(26):2503-5.
  14. Huang AJ, Sawaya GF, Vittinghoff E, Lin F, Grady D. Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women. Menopause. 2009 Jul-Aug; 16(4):639-43.
  15. Melnikow J, McGahan C, Sawaya GF, Ehlen T, Coldman A. Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study. J Natl Cancer Inst. 2009 May 20; 101(10):721-8.
  16. Grady D, Sawaya GF, Johnson KC, Koltun W, Hess R, Vittinghoff E, Kristof M, Tagliaferri M, Cohen I, Ensrud KE. MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trial. Menopause. 2009 May-Jun; 16(3):458-65.
  17. Fukuchi E, Sawaya GF, Chirenje M, Magure T, Tuveson J, Ma Y, Shiboski S, Da Costa M, Palefsky J, Moscicki AB, Makunike-Mutasa R, Chipato T, Smith-McCune KK. Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe. Sex Transm Dis. 2009 May; 36(5):305-11.
  18. Ensrud KE, Stone KL, Blackwell TL, Sawaya GF, Tagliaferri M, Diem SJ, Grady D. Frequency and severity of hot flashes and sleep disturbance in postmenopausal women with hot flashes. Menopause. 2009 Mar-Apr; 16(2):286-92.
  19. Petitti DB, Teutsch SM, Barton MB, Sawaya GF, Ockene JK, DeWitt T. Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence. Ann Intern Med. 2009 Feb 3; 150(3):199-205.
  20. Chan BK, Melnikow J, Slee CA, Arellanes R, Sawaya GF. Posttreatment human papillomavirus testing for recurrent cervical intraepithelial neoplasia: a systematic review. Am J Obstet Gynecol. 2009 Apr; 200(4):422.e1-9.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.

Home • Terms of Use • Site Map • Contact Us       © 2002 - 2012 The Regents of The University of California